STARLIX

This brand name is authorized in United States. It is also authorized in Austria, Cyprus, Estonia, Ireland, Lithuania, Poland, Romania, Singapore, South Africa.

Active ingredients

The drug STARLIX contains one active pharmaceutical ingredient (API):

1	Nateglinide UNII 41X3PWK4O2 - NATEGLINIDE
	Nateglinide is an amino acid (phenylalanine) derivative, which is chemically and pharmacologically distinct from other antidiabetic agents. Nateglinide is a rapid, short-acting oral insulin secretagogue. Its effect is dependent on functioning beta cells in the pancreas islets.
	Read more about Nateglinide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
STARLIX Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BX03	Nateglinide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BX Other blood glucose lowering drugs, excl. insulins
Discover more medicines within A10BX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1013892, 1013904, 1013915, 1080896, 1080908, 1080919, 1080920, 1080931, 1080942, 1092697, 1092709, 1092710, 1092721, 1092732, 1092743, 1092754, 1092765, 1092776, 1092787, 1092798, 1092800
IE	Health Products Regulatory Authority	45428
LT	Valstybinė vaistų kontrolės tarnyba	1008568, 1010504, 1030866, 1030867, 1030868, 1030869, 1030870, 1030871, 1030872, 1030873, 1030874, 1030875, 1030876, 1030877, 1030878, 1030879, 1030880, 1030881, 1030882, 1030883, 1030884
PL	Rejestru Produktów Leczniczych	100104357, 100104363, 100104370
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W51732001, W51732002, W51732003, W51732004, W51732005, W51732006, W51732007, W51733001, W51733002, W51733003, W51733004, W51733005, W51733006, W51733007, W51758001, W51758002, W51758003, W51758004, W51758005, W51758006, W51758007
SG	Health Sciences Authority	11445P, 11448P
US	FDA, National Drug Code	0078-0351, 0078-0352
ZA	Health Products Regulatory Authority	35/21.2/0039, 35/21.2/0040